Obesity as a Disease - Our Position

Total Body Balance

Medical Weight Loss Center

Terms and Measuring Sticks
Weight Loss Programs Available Reverse Heart Disease Now Home Page
Articles About Our Program Heartfixer Welcome Page
Case Studies - 1st 25 Patients

at

Comprehensive Heart Care

Comprehensive Heart Care Home Page
New Patient Information Medical Topics Section
Total Body Balance Home Page

Outcome Statistics

This page presents our outcomes in graphic form.  Please refer to the Case Studies page for information regarding the treatment response and course of our first 25 patients.

                                                                                                     

Group Results - First 450 Female and First 180 Male Patients to complete an Initial Course of Modified hCG Therapy 
                  

 

 

 

 

 

 

                                                                                                                                                                                                                                      
                                                                   

                                         One Hundred Fifty Female Patients have completed Two Courses of Modified hCG Therapy
                                      
Total loss refers to the sum of weight loss in the two cycles combined and net loss refers to baseline minus final weight.
                                          Some patients were less adherent to the protocol during round two and many utilized the 26 day protocol - their results are included. their                                                                                                                                                             

 

 

 

 

 

       

                                                                                      

                                            
                                            Thirty Six Female Patients have completed Three Courses of Modified hCG Therapy
                                    
Total loss refers to the sum of weight loss in the two cycles combined and net loss refers to baseline minus final weight.
                                      Some patients were less adherent to the protocol during round two and/or utilized the 26 day protocol - their results are included. the

                                                 

 

 

 

 

 

 

                                                     
          

                                                 Fifty Three Male Patients completed Two Courses of Modified hCG Therapy
                                            Total loss refers to the sum of weight loss in the two cycles combined and net loss refers to baseline minus final weight.
                                   Some patients were less adherent to the protocol during round two and/or utilized the 26 day protocol - their results are included. t
he
                                                                                                                    

 

                                                    

 

                                           

 

                                              

 

 

                                                    Seven Male Patients have completed Three Courses of Modified hCG Therapy
                                    
Total loss refers to the sum of weight loss in the two cycles combined and net loss refers to baseline minus final weight.
                                      Some patients were less adherent to the protocol during round two and/or utilized the 26 day protocol - their results are included. the

 

 

 

 

 

 

 

 


Weight Loss by Female and Male Treatment Groups (30 Female and 10 Male Patients per Group)
                                                                                                                                                      

 

 

 

 

 

 

 

                                                                                                                             

Thirty Five Women completed a 23 Day Course of Modified hCG Therapy
  
In some patients this was a round two or a round three following an initial 43 day program.   

 

 

 

 

 

 

 

 


Fifteen Men have completed a 23 Day Initial Course of Modified hCG Therapy
    

 

 

 

 

 

 

 

 

 

First Ten Female Patients who have completed an Initial Course of Modified hCG Therapy       
                           

                                                
                                                

 

 

 

 

 




First Ten Male Patients who have completed an Initial Course of Modified hCG Therapy

                       

 

 

 

 

 

 

 

 

Second Ten Male Patients who have completed an Initial Course of Modified hCG Therapy    

                         

                                    

          

 

 

 

 

 

                  
            Second Ten Female Patients who have completed an Initial Course of Modified hCG Therapy
                                         

                         

                                        

                                

 

 

 

 

 

    
      Third Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy
 

 

                               
                                  

 

 

 

 

 

 
Third Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy
                              

 

                                           

                                            

 

 

 

 

Fourth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy      

 

 

 

 

 

 

 

 

 

Fourth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy


 

 

 

 

 

 

 



Fifth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

 

Fifth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 
 

 

 

 

 

  

 

 

Sixth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 


Sixth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy
       

 

 

 

 

     

 

 

 

Seventh and Eighth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Ninth and Tenth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Seventh Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 


 

Eighth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 


Ninth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

 

Tenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

 

Eleventh and Twelfth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Eleventh Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 


Twelfth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

Thirteenth and Fourteenth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 


 

Thirteenth and Fourteenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Fifteenth and Sixteenth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Fifteenth and Sixteenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

 

Fifteenth and Sixteenth Group of Ten Male Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

 

Seventeenth and Eighteenth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

 

Nineteenth and Twentieth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Twenty First and Twenty Second Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 


Twenty Third and Twenty Fourth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

Twenty Fifth and Twenty Sixth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Twenty Seventh and Twenty Eighth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Twenty Ninth and Thirtieth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Thirty First and Thirty Second Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Thirty Third and Thirty Fourth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Thirty Fifth and Thirty Sixth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Thirty Seventh and Thirty Eighth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Thirty Ninth and Fortieth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Forty First and Forty Second Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Forty Third and Forty Fourth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

 

 

 

 

Forty Fifth and Forty Sixth Group of Ten Female Patients to complete an Initial Course of Modified hCG Therapy

 

 

 

 

Patients with Limited Adherence to the Diet   

      Most of our patients followed the diet to the letter - and then were rewarded with a significant weight loss.  Others followed the diet most of the time, breaking away occasionally in relation to hunger or social obligations (we are all human); their statistics are included in the overall results.  Excluded from the main statistics and presented below are patients who did not follow the program most of the time.  As you can see, when you do not follow Dr. Simeons' guidelines you do not obtain a significant reduction in weight. 

   

 

 

 

 

 

 

 

 

Early Discontinuation
A small number of patients (»10% of those who start) stopped early or dropped out of the program for the reasons given below.

Patient Reason Patient Reason
W1dc Hunger; Lost Motivation M1dc Prostatitis
W2dc Hunger M2dc Fever and URI
W3dc No Return Call M3dc Disc Disease Flare Up
W4dc Lost hCG M4dc No Return Call
W5dc Lost Motivation M5dc Hunger & Frustration
W6dc Schedule Conflict M6dc-2 Lost Motivation Round Two
W7dc Lost Motivation M7dc No Return Call
W8dc Possible Allergy M8dc Diverticular Disease
W9dc No Return Call M9dc-2 Lost Motivation Round Two
W10dc-2 Lost Motivation Round 2 M10dc No Return Call
W11c No Return Call M11dc Broke Rules & Quit
W12dc Surgery Required M12dc Lost Motivation
W13dc Lost Motivation M13dc-2 Broke Rules & Quit
W14dc Quit M14dc-2 Friend Died
W15dc-2 Lost Motivation Round 2 M15dc Quit
W16dc-2 Lost Motivation Round 2 M16dc Quit
W17dc Quit M17dc-2 Lost Motivation Round 2
W18dc Caught a cold M18dc-2 Lost Motivation Round 2
W19dc Caught a cold M19dc-4 Lost Motivation Round 4
W20dc No Return Call M20dc Back Issues
W21dc Lost Motivation W44dc Quit
W22dc Quit W45dc Quit
W23dc Quit W46dc-2 Lost Motivation Round 2
W24dc-3 Lost Motivation Round 3 W47dc Quit
W25dc Lost Motivation W48dc-2 Pneumonia
W26dc-2 Lost Motivation Round 2 W49dc-2 Lost Motivation Round 2
W27dc-2 Lost Motivation Round 2 W50dc Quit
W28dc-3 Lost Motivation Round 3 W51dc-2 Lost Motivation Round 2
W29dc Lost Motivation W52dc Quit
W30dc No Return Call W53dc Quit
W31dc-2 Quit W54dc Family Problems
W32dc-2 Refused Office Visits W55dc Quit at Two Weeks
W33dc Migraine Headache W56dc-2 Family Problems
W34dc Quit W57dc No Show/No Response
W35dc Quit W58dc Colon Issues
W36dc-2 Lost Motivation Round 2 W59dc Quit at Two Weeks
W37dc Quit W60dc-2 Lost Motivation Round 2
W38dc Quit W61dc-2 Lost Motivation Round 2
W39dc Quit W62dc-3 Lost Motivation Round 3
W40dc-2 Quit Round 2 W63dc-2 Lost Motivation Round 2
W41dc Quit W64dc Quit
W42dc Quit W65dc Quit
W43dc Quit W66dc No Show/No Response
W44dc No Show W67dc No Show/No Response
W45dc No show W68dc Pregnancy
W42dc No Show W69dc Quit
W43dc Quit W70dc Quit
W71dc Quit W77dc Quit
W72dc Quit W78dc-2 Lost Motivation Round 2
W73dc-3 Lost Motivation Round 3 W79dc-2 Lost Motivation Round 2
W74dc-2 W80dc-2 Pregnancy
W75dc-2 Family Stress W81dc-2 Lost Motivation Round 2
W76dc-2 W82dc-3 Lost Motivation Round 3

      Our quit rate for round one is 12% for women and 7% for men.  Patients who dropped out or stopped early did so primarily due to loss of motivation and/or hunger.  We did not feel that the hCG program was the cause of M1dc's prostatitis, M3dc's disc disease flare up, M8dc's diverticular disease, or M2dc's upper respiratory tract infection.  However, 10 days later M2dc experienced gall bladder inflammation, leading to cholycystectomy (surgical removal of the gall bladder).  W98 also required cholycystectomy towards the end of her 40 day program.  A third patients required cholycystectomy eight weeks after completion the program.  Rapid weight reduction by any means can lead to inflammation within the gall bladder (probably only in individuals with pre-existent gall bladder disease but we cannot say this with certainty).  Thus our gall bladder event rate is 3 cases amongst 560 patients undergoing 833 rounds of hCG therapy (0.5% of patients treated).  Two patients experienced a transient flare up of gout.  These side-effects of hCG-assisted weight reduction are not unexpected and are discussed by Dr. Simeons in his book.  A handful of patients experienced upper respiratory infections and stopped early; we feel this was the seasonal flu and not a direct complication of their weight loss program.  Several patients who were doing well became diagnosed with an unrelated problem and had to drop out early to begin treatment.  Two women dropped out early as they found they were pregnant (while risk to the baby is not expected with hCG, we advise against conceiving while on our program - one women was felt to be infertile but fertility returned with weight loss).  A small number of patients developed urinary tract infection or pneumonia while on the program.  These infections are likely incidental to weight loss, and not caused by weight loss.  However, if significant infection occurs, we counsel you to stop hCG and immediately increase caloric intake to a Phase 3 level, emphasizing protein over carbohydrate, as 500 calories a day is not sufficient when your physiology is marshaling its resources to defend you against bacterial invasion.  The program can be restarted (including the gorge days) after you have recovered.   

                                                                                                               Current Status (as of 3/26/11)

One Full Round of Weight Reduction Completed  400 Women and 160 Men

Two Rounds Completed

130 Women and 50 Men

Three Rounds Completed

36 Women and 7 Men

26 Day Round One Completed 35 Women and 15 Men

 Currently Undergoing Round One

   19 Women and 4 Men

Currently Undergoing Rounds Two or Three

  26 Women and 7 Men

Limited Dietary Adherence

50 Women and 22 Men

Early Discontinuation of Round One

53 Women and 13 Men

Early Discontinuation of Round Two

22 Women and 6 Men

Early Discontinuation of Subsequent Rounds

5 Women and 1 Man

Program Modified

2 Women

Cosmetic Weight Loss

4 Women

 

      Please Note -  It is the position of the FDA and FTC that HCG has not been demonstrated to be effective adjunctive therapy in the treatment of obesity.  There is no substantial evidence that it increases weight loss beyond that resulting from caloric restriction, that it causes more attractive or “normal” distribution of fat, or that it decrease the hunger and discomfort associated with calorie-restricted diets.